AMNEAL PHARMACEUTICALS, INC. AMRX

19.77 (0.04) (0.20%) as of 25 Sep
Market cap
$6.3B
P/E
39.5×
Growth Flags show if company had growth for consecutive years
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
54.78 0.00 0.00 0.00 69.22 8.61 0.00 0.00 0.00 0.00
P/S ratio
1.31 0.88 0.44 0.14 0.34 0.34 0.39 1.04 0.96 0.96
P/FCF ratio
17.34 11.12 3.81 6.76 1.61 2.15 0.00 9.65 11.38 11.38
P/Operating CF
30.30 20.72 7.75 (13.67) 11.28 6.36 (12.51) 6.63 39.76 39.76
P/B ratio
0.00 0.00 52.64 1.73 1.94 1.95 1.84 1.92 18.03 18.03
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
2.06 1.74 1.50 1.36 1.53 1.61 1.95 2.52 1.56 1.56
EV/EBITDA
9.70 9.47 8.07 19.53 8.11 9.55 2,229.97 31.30 4.39 4.39
EV/Operating CF
18.26 16.51 10.40 46.16 13.25 8.45 1,862.71 16.76 7.95 7.95
EV/FCF
27.27 22.13 13.01 63.75 7.21 10.24 (33.18) 23.50 18.63 18.63
Quick Ratio
1.37 0.79 0.84 1.03 1.36 1.46 1.38 1.27 1.50 1.37
Current Ratio
2.17 1.41 1.63 1.88 2.24 2.29 2.20 2.32 2.60 1.96
Net Debt/EBITDA
3.62 4.71 5.71 17.46 6.30 7.54 1,783.00 18.45 4.76 2.03
Debt/Assets
71.41% 72.62% 76.04% 71.63% 69.77% 71.79% 73.43% 61.83% 110.62% 45.60%
Debt/Equity
(36.83) (23.22) 131.96 14.79 7.49 8.34 7.76 3.00 (3.95) 1.33
Asset Turnover
0.84 0.80 0.66 0.57 0.53 0.52 0.41 0.58 0.65 0.54
Operating CF/Net income
4.72 (2.52) (4.11) (0.50) 22.76 4.16 0.00 (11.96) 0.00 0.00
Capex/Depreciation
(0.46) (0.28) (0.29) (0.36) (0.20) (0.27) (0.39) (0.47) (2.26) (3.45)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(79.69%) 261.19% (82.35%) (47.19%) 2.98% 26.33% (58.23%) (8.03%) 0.00% 0.00%
ROA
2.01% (3.35%) (2.31%) (3.36%) 0.27% 2.37% (9.03%) (0.73%) 0.00% 0.00%
ROIC
10.97% 6.73% 4.99% (2.07%) 3.34% 1.98% (5.39%) (0.36%) 14.86% 13.96%
Return on Tangible Assets
4.89% (13.24%) (8.58%) (11.52%) 0.78% 6.73% (31.81%) (1.64%) 0.00% 0.00%
Average Days of Receivables
108.29 101.40 93.73 122.47 115.72 117.29 136.04 105.86 129.80 93.52
Research and Development Expense of Revenue
6.17% 6.83% 6.85% 8.85% 9.64% 9.03% 11.56% 11.68% 16.58% 17.58%
Selling, General and Administrative Expense of Revenue
17.45% 17.05% 17.95% 18.07% 17.46% 16.40% 17.81% 13.70% 10.55% 11.66%
Intangible Assets out of Total Assets
0.32 0.38 0.43 0.45 0.45 0.46 0.49 0.48 0.05 0.45
Share Based Compensation of Revenue
1.06% 0.99% 1.12% 1.44% 1.36% 1.04% 1.33% 10.08% 0.00% 0.00%
Graham Net Nets
(0.47) (0.83) (1.97) (6.92) (2.88) (3.13) (3.31) (1.26) (0.54) (0.54)
Graham Number
0.00 1.74 0.00 0.00 1.96 5.29 0.00 0.00 0.00 0.00
Earnings Yield
1.83% (4.80%) (7.95%) (40.76%) 1.44% 11.61% (57.26%) (45.58%) (43.44%) (43.44%)
Free Cash Flow Yield
5.77% 8.99% 26.24% 14.80% 62.30% 46.42% (15.03%) 10.37% 8.79% 8.79%
Revenue per Share
9.63 9.04 13.59 14.66 14.06 13.51 12.31 13.07 13.97 14.34
Operating CF per Share
1.09 0.96 1.96 0.43 1.62 2.57 0.01 1.97 3.16 1.62
Capex per Share
(0.36) (0.24) (0.39) (0.60) (0.32) (0.45) (0.74) (0.56) (1.54) (1.75)
Free Cash Flow per Share
0.73 0.71 1.57 (0.17) 1.30 2.12 (0.72) 1.40 1.62 (0.13)
Cash per Share
0.99 0.38 0.56 0.23 1.72 2.35 1.16 1.72 1.05 2.54
Shareholders Equity per Share
(0.23) (0.35) 0.11 1.22 2.46 2.34 2.63 7.04 (5.08) 8.79
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(0.23) (0.35) 0.11 1.22 2.46 2.34 2.63 7.04 (5.08) 8.79
Free Cash Flow
227.73 220.11 276.39 (25.49) 194.18 312.82 (95.73) 178.49 119.92 (9.55)
Working Capital
1,029.55 458.04 531.27 659.02 842.87 874.64 659.80 732.79 475.05 309.82
Capital Expenditures
(112.26) (74.99) (69.19) (90.59) (47.64) (66.19) (97.43) (71.74) (114.27) (124.61)
Net Current Asset Value
(1,838.43) (2,023.15) (2,074.69) (2,203.54) (2,052.58) (2,109.56) (2,108.89) (2,169.73) (945.54) (567.90)
EV/EBIT
15.76 19.54 17.59 0.00 20.99 35.14 0.00 0.00 4.88 4.88
Capex to Sales
0.04 0.03 0.03 0.04 0.02 0.03 0.06 0.04 0.11 0.12
Net Profit Margin
2.39% (4.18%) (3.51%) (5.88%) 0.51% 4.57% (22.25%) (1.26%) 0.00% 0.00%
Price to Operating Income
10.02 9.81 5.15 0.00 4.67 7.39 0.00 0.00 2.98 2.98
Other line items
Depreciation/Fixed assets
0.56 0.62 0.54 0.53 0.47 0.51 0.52 0.28 0.10 0.15
Cash ROIC
(3.59%) (5.09%) (3.70%) (13.76%) (8.08%) (2.77%) (14.92%) (7.72%) (21.28%) (7.23%)
Accounts Receivable Turnover
3.61 4.02 3.53 3.15 3.21 3.20 2.99 3.91 3.29 3.48
Accounts Payable Turnover
2.55 2.79 2.93 2.68 2.33 2.44 2.49 2.67 4.00 7.30
Inventory Turnover
3.13 2.97 2.83 2.80 2.70 3.13 3.04 2.55 2.21 2.80
Average Days of Payables
145.83 151.36 124.06 137.60 144.75 163.72 145.46 198.37 140.09 51.14
Days of Inventory on Hand
116.14 126.05 134.90 135.70 134.84 131.28 109.23 176.30 204.29 152.00
Average Receivables
835.91 695.45 678.49 703.03 652.03 623.23 544.24 424.95 314.23 292.67
Average Payables
748.38 635.06 536.43 531.77 568.61 559.68 510.96 354.61 126.87 57.64
Average Inventory
609.38 596.92 556.06 510.06 490.02 435.86 419.14 370.63 229.63 150.41
Average Assets
3,589.86 3,487.01 3,635.96 3,869.50 3,972.85 3,835.96 4,009.31 2,847.31 1,582.45 1,872.75
Average Common Equity
(90.42) (44.75) 102.00 275.48 355.95 345.86 621.58 260.39 124.20 843.19

Fold the line items

Columns are period end dates